Skip to main content
. 2021 Nov 3;12:6340. doi: 10.1038/s41467-021-26570-8

Fig. 5. The HAT inhibitor A-485 radiosensitizes cells harboring CREBBP and EP300 mutations.

Fig. 5

a, b Clonogenic survival following irradiation and either A-485 (active) or A-486 (inactive) in CREBBP/EP300 mutant (a) or wild-type (b) HNSCC cells. c Surviving fraction at 4 Gy for each cell line (highest dose of A-485/A-486 shown). d, e TUNEL assay (d) and caspase 3 cleavage (e) in UM-SCC-47 (CREBBP mut), and HN5 (CREBBP/EP300 mut) and HN31 (CREBBP/EP300 wt) cells treated with radiation and either A-485 (active) or A-486 (inactive). For ae, a minimum of three independent samples for each condition are shown and are presented as mean values +/− SEM with (*, #) -p < 0.05 vs. control (*) and A-486 (#). p-values are two-sided and derived from ANOVA with post hoc analysis adjusted for multiple comparisons.